Obstetrics Flashcards
Define Gravidity (1)
Total number of pregnancies she has had, including the current one
Define Parity (1)
Pregnancies that resulted in delivery beyond 24 weeks
What does it mean if she is para 2+1?
She has had 2 deliveries after 24 weeks and 1 pregnancy which ended before 24 weeks
What is the gravidity of a para 1+2 who is currently pregnant?
4
What is the gravidity and parity of a first time Mum who has had one abortion?
gravidity 2
para 0+1
Dating a Pregnancy (1)
Expected delivery date = 1 year and 7 days after the LMP minus 3 months
If LMP was 09/04/20, what is due date?
16/01/21
Antenatal Booking Visit (5)
8-12 weeks
General info + advice (including folic acid until 13 weeks)
Routine care: BP, urine dipstick, BMI
Booking bloods: FBC, blood group, rhesus status, HIV, hep B, syphilis serology
Booking urine culture for asymptomatic bacteriuria
General Changes in Pregnancy (3)
Ligamentous laxity: ligaments relax to soften symphysis pubis but this can cause SP joint dysfunction, back and joint pain
Linea nigra
Spider naevi
Endocrine Changes in Pregnancy (3)
Breasts: increased oestrogen increases size and vascularity, leading to tenderness and colostrum
Thyroid: BhCG mimics T4 leading to reduced TSH, mimicking hyperthyroidism
Placenta: BhCG causes morning sickness, progesterone produced by placenta increases body temperature
GI Changes in Pregnancy (2)
Stomach: progesterone mediates pyloric sphincter relaxation, increased bile in stomach, reduced peristalsis
Large bowel: increased progesterone and reduced motilin cause constipation
Cardiovascular Changes in Pregnancy (4)
Antenatal cardiac output: circulating volume increases by 50-70%, high CO, high SV, low VR, high HR when supine due to IVC
Intrapartum cardiac output: 100% increase in CO2 due to autotransfusion of contractions and catecholamine release
Postnatal cardiac output: VR high above pre-pregnancy levels in first 2 weeks, HR normal after 2 weeks, CO2 normal by 24 weeks
BP: reduced in first trimester and continues to fall until 20-24 weeks, then increases to pre-pregnancy levels at term
Respiratory Changes in Pregnancy (2)
Increased O2 demand: increased ventilation, increased RR, increased TV (can cause SOB), peak flow + FEV1 unchanged
Progesterone acts centrally to reduce PCO2 leading to physiological respiratory acidosis
Renal Changes in Pregnancy (3)
Dilation of collecting system: increased blood flow to kidneys, high gFR and creatinine clearance
Increased renin and angiotensin in response to hypotension
Increased protein excretion causing oedema
Haematological Changes in Pregnancy (4)
Increased plasma volume: low Hb, MCV normal, low platelets
Increased iron and folate requirements
Increased WCC
Hypercoagulability (DVT + PE)
Sonography
Early Pregnancy USS (<11w) (3)
Not routine
Purpose: date pregnancy/determine location
Indications: hyperemesis gravidarum, bleeding, pain
Sonography Early USS (10-13+6w) (2)
Purpose: viability, multiples, anomalies incompatible with life
Calculate gestational age: crown rump length (or BPD if 12-20w)
Sonography Anomaly scan (18-20+6w) (1)
Purpose: identify structural problems
Sonography Fetal echocardiography (5)
If high risk of cardiac abnormality Maternal/family history Increased nuchal translucency Drugs in pregnancy Pre-existing DM
Sonography
Fetal growth scans (2)
If require accurate gestational age: SGA/LGA
Abdominal circumference + head circumference + femur length used to calculate estimated fetal weight, as well as liquour volume
Sonography Doppler ultrasound (3)
Blood flow to uterus, placenta and fetus
Uterine artery Doppler: high resistance indicates PET, IUGR
Umbilical artery Doppler: high resistance indicates placental failure + risk of intrauterine death
Down Syndrome Screening
Risk (2)
1:700
Increased with maternal age
Down Syndrome Screening Normal screening (4)
Offered to all
Only provides estimation of risk (need further tests to confirm)
Combined test at 11-13+6w: high serum BhCG and low PAPP-A (pregnancy associated plasma protein A) + increased ultrasound fetal nuchal translucency
Triple/quadruple test if 15-20w: reduced alpha-fetoprotein + unconjugated oestriol + high BhCG (+inhibin A)
Down Syndrome Screening Prenatal Diagnosis (2)
Chorionic villus sampling at 10-14w
Amniocentesis if >15w
Testing for Neural Tube Defects (4)
Screening not routine, offered if personal/family history
1st trimester USS: anencephaly and spina bifida detectable
2nd trimester biochemical screening: maternal AFP >2 warrant further testing
Anomaly scan detects 90% (lemon shaped skull and curved cerebellum)
Pre-Existing Hypertension in Pregnancy
Epidemiology (1)
3-5% of pregnancies
Pre-Existing Hypertension in Pregnancy
Investigations (2)
Urinalysis (no proteinuria, but these women are at a high risk of pre-eclampsia)
Investigate for an underlying cause if a new finding (eg. CKD, aortic coarctation)
Pre-Existing Hypertension in Pregnancy Preconception Management (2)
Stop ACE-i, ARB, thiazides as risk congenital abnormality
Labetalol (combined alpha/beta blocker) or methyldopa
Pre-Existing Hypertension in Pregnancy Antenatal Management (3)
Aim BP <150/90 or 140/90 if end-organ damage
Labetalol/methyldopa
Fetal US every 4 weeks from 28 weeks to assess fetal growth, amniotic fluid volume and umbilical artery dopplers
Pre-Existing Hypertension in Pregnancy Intrapartum Management (3)
Monitor BP hourly if <159/109 or continuously if >160/100
Continue drugs
Give oxytocin alone for 3rd stage because ergometrine causes severe hypertension, risking stroke
Pre-Existing Hypertension in Pregnancy Postnatal Management (3)
Check BP on days 1,2 and once between days 3-5 and then at 2 weeks
Change methyldopa after delivery as risks postnatal depression
Avoid diuretics if breastfeeding
Pre-Existing Hypertension in Pregnancy
Complications (3)
Pre-eclampsia
IUGR
Placental abruption
Gestational Hypertension
Epidemiology (1)
6-7% of pregnancies
Gestational Hypertension
Definition (1)
Hypertension (>140/90) in 2nd half of pregnancy in the absence of proteinuria or other features of pre-eclampsia (although at higher risk of developing it)
Gestational Hypertension
Investigations (3)
Urinalysis: no proteinuria
Bloods: FBC, U&E, AST/ALT and bilirubin if high BP (at presentation and weekly)
USS: 4-weekly growth scans
Gestational Hypertension Antenatal Treatment (2)
140-159/90-109: labetalol or methyldopa
>160/110: admit, if can’t stabilise on anti-hypertensives then deliver
Gestational Hypertension Intrapartum Treatment (2)
Continue anti-hypertensives
BP measured hourly (continuously if >160/110), do operative delivery if won’t settle
Gestational Hypertension Postnatal Treatment (2)
Reduce when 130/80
Stop methyldopa
Pre-Eclampsia
Epidemiology (1)
5% of pregnancies
Pre-Eclampsia
Pathology (2)
Failure of trophoblastic invasion of spiral arteries leaving them vasoactive (when they are properly invaded they can’t clamp down in response to vasoconstrictors and thus protects placental flow)
Increase in BP to compensate
Pre-Eclampsia Risk factors (10)
Previous severe or early (<20 weeks) onset pre-eclampsia Chronic hypertension or previous gestational hyperetension CKD Diabetes 1st pregnancy Pregnancy interval >10 years Increasing maternal age High BMI Multiple pregnancy Family history of pre-eclampsia
Pre-Eclampsia
Symptoms (5)
Headache Flashing lights Epigastric/right upper quadrant pain Nausea and vomiting Facial/finger/lower limb swelling
Pre-Eclampsia
Investigations (7)
Urinalysis: proteinuria
Protein:Creatinine ratio >30
FBC + LFT: HELLP syndrome (Haemolysis= +bilirubin, Elevated liver enzymes= high AST + ALT, Low Platelets)
Clotting: prolonged PT + APTT
U&E + creatinine: high creatinine
CTG
Growth scan with umbilical artery Doppler (may have IUGR + polyhydramnios)
Pre-Eclampsia Traget BP (1)
135/85
Pre-Eclampsia Antenatal Management (6)
1st labetalol
2nd nifedipine
3rd methyldopa
Induction at 37 weeks
Admit if severe (>160/110), IV labetalol
If very severe, give magnesium sulphate for seizure prophylaxis
Pre-Eclampsia Intrapartum Management (4)
If planned and uncomplicated just continue anti-hypertensives and monitor BP hourly or every 15-30mins if severe
Early C-section (<37 weeks) if unable to control BP, low sats, HELLP, eclampsia, abruption, worrying fetal monitoring
Deliver at 37 weeks onwards in emergency- induction if not severe, otherwise C-section
3rd stage only use oxytocin because Synto/Ergometrine contraindicated due to high risk of severe hypertension –> stroke
Pre-Eclampsia
Complications (8)
Eclampsia HELLP syndrome Microaneurysms develop in arteries (contributing to DIC) Cerebral haemorrhages IUGR Renal failure Placental abruption Stillbirth
Eclampsia
Definition (2)
Tonic-clonic seizure and pre-eclampsia (occurs in 1% of pregnancies with pre-eclampsia)
Most fits occur postnatally
Eclampsia
Treatment (4)
Magnesium sulfate for prevention and treatment (IV bolus 4g over 5-10min then 1g/h for 24h)
For repeated seizures: diazepam
If antenatal/intrapartum then C-section once stable
Manage 3rd stage with oxytocin as Synto/Ergometrine are contraindicated as risk severe hypertension + stroke
HELLP Syndrome
3
Haemolysis, Elevated Liver enzymes, Low Platelets
Symptoms: epigastric/RUQ pain, nausea and vomiting, dark urine due to haemolysis
Treatment: delivery and same treatment as eclampsia§§
Pre-Existing Diabetes
Pathology (3)
Maternal insulin requirements increase
Because placental lactogen, beta hCG, progesterone and cortisol are anti-insulin
Maternal glucose crosses the placenta leading to fetal hyperinsulinaemia and macrosomia
Pre-Existing Diabetes
Pre-pregnancy management (4)
Optimise control (aim glucose 4-7mmol/l and HbA1c <48mmol/l)
5mg folic acid daily
Stop oral hypoglycaemics except metformin
Stop ACE-i, ARBs and statins
Pre-Existing Diabetes Antenatal management (2)
Continue insulin type 1 and metformin type 2 (although may require insulin for tighter control)
Growth scans every 4 weeks from 28 weeks
Pre-Existing Diabetes Intrapartum Management (4)
Induction/C-section at 38 weeks
Corticosteroids to promote fetal lung maturity if premature
Continuous fetal monitoring
Sliding scale infusion of insulin (halve rate of infusion after placental delivery in type 1 and stop in type 2)
Pre-Existing Diabetes Postnatal Management (1)
Metformin and insulin fine for breastfeeding
Pre-Existing Diabetes Maternal complications (3)
Hypoglycaemia unawareness (especially 1st trimester)
Increased risk of pre-eclampsia
Increased risk of infection
Pre-Existing Diabetes Fetal complications (7)
Miscarriage Increased risk of malformation Macrosomia (risk of shoulder dystocia) Polyhydrammnios Growth restriction Preterm labour Stillbirth
Gestational Diabetes Risk Factors (6)
BMI >30 1st degree relative Previous baby >4.5kg Previous gestational diabetes Increasing age Ethnicity
Gestational Diabetes
Investigations (2)
OGTT (if any risk factors) >7.8
HbA1c to exclude undetected pre-pregnancy type 2 diabetes
Gestational Diabetes
Treatment (2)
Diet and exercise for 1-2 weeks (after this start medical therapy)
Metformin/insulin
Gestational Diabetes
Complications (7)
Type 2 DM (50%- so give lifelong dietary advice and follow up) Macrosomia Birth trauma Shoulder dystocia Polyhydramnios Prematurity Stillbirth
Hyperemesis Gravidarum
Definition (1)
Persisting vomiting in pregnancy which causes weight loss (>5% of pre-pregnancy weight) and ketosis
Hyperemesis Gravidarum Risk factors (3)
Multiple pregnancy (due to high BhCG)
Molar pregnancy
History of hyperemesis
Hyperemesis Gravidarum
Signs + symptoms (5)
Inability to keep food/fluids down Weight loss Dehydration Electrolyte disturbance with hypokalaemia and hyponatraemic shock Haematemesis from Mallory-Weiss tear
Hyperemesis Gravidarum
Investigations (4)
Urinalysis: ketones
U&E: hypokalaemia, hyponatraemia
FBC: raised haematocrit
US: diagnose multiple pregnancy and exclude a mole
Hyperemesis Gravidarum
Treatment (5)
Admit for rehydration and correction of metabolic disturbance if unable to keep anything down despite oral anti-emetics
Fluids: 0.9% NaCl + K or Hartmann’s (maintenance fluids)
Folic acid
Anti-emetics eg. promethazine, cyclizine, metoclopramide
Thiamine (eg. pabrinex) to avoid Wernicke’s encephalopathy
Hyperemesis Gravidarum
Complications (5)
Wernicke encephalopathy Mallory-Weiss tear VTE SGA Pre-term birth
Venous Thromboembolism in Pregnancy
Pathology (3)
Increased venous stasis
Trauma to pelvic vessels at delivery
In factors X, VIII and fibrinogen
Venous Thromboembolism in Pregnancy Risk factors (7)
Increasing age High BMI Increasing parity Smoking Pre-eclampsia Family history of unprovoked DVT Multiple pregnancy
Venous Thromboembolism in Pregnancy
Signs + symptoms (2)
DVT: swelling, pain, redness
PE: SOB, chest pain, haemoptysis